RecruitingNot ApplicableNCT06988020

"Pseudo-scanner" MRI Sequences for the Detection of Bone Lesions in Multiple Myeloma

Evaluation of Optimised Whole-body MRI Examinations Incorporating "Pseudo-scanner" Sequences (ZTE, "Zero Echo Time" AND Lava Flex) for the Detection of Bone Lesions in Multiple Myeloma


Sponsor

Cliniques universitaires Saint-Luc- Université Catholique de Louvain

Enrollment

45 participants

Start Date

Apr 22, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

Recent work has confirmed the diagnostic performance of pseudo-CT sequences for detecting osteolytic lesions. Their integration into whole body MRI (WB MRI) could transform the diagnostic approach to MM, by allowing a combined assessment of bone marrow involvement, tissue viability and osteolysis, during a single non-irradiating imaging examination. Since the preliminary work mentioned above, optimizations have been made to the pseudo-CT sequences, including the addition of deep learning (correcting noise in the images) and the correction of chemical shift artifact (linked to the coexistence of hydrated tissue and fatty tissue), which carry real hope of improving their diagnostic potential and accuracy.


Eligibility

Min Age: 18 Years

Inclusion Criteria3

  • Patient with newly diagnosed multiple myeloma, for whom bone imaging is required for staging.
  • Recurrent patient after intensive treatment (high dose chemotherapy, bone marrow transplant, etc.).
  • Patient requiring a PET / CT considered as the technique of choice in these stages of the disease.

Exclusion Criteria3

  • Implanted material incompatible with MRI.
  • Severe claustrophobia.
  • Pregnant women

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEMRI

Whole body MRI including ZTE sequences


Locations(1)

Cliniques universitaires Saint-Luc

Brussels, Belgium

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06988020